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DOCK8-DEFICIENT CD4+ T CELLS ARE BIASED TO A TH2 EFFECTOR FATE AT 1 
THE EXPENSE OF TH1 AND TH17 CELLS. 2 
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ABSTRACT 44 
Background: Dedicator of cytokinesis 8 (DOCK8) deficiency is a combined 45 
immunodeficiency caused by autosomal recessive loss-of-function mutations in DOCK8. This 46 
disorder is characterised by recurrent cutaneous infections, elevated serum IgE, and severe 47 
atopic disease including anaphylaxis to foods. However, the contribution of defects in CD4+ T 48 
cells to disease pathogenesis in these patients has not been thoroughly investigated.  49 
Objective: To investigate the phenotype and function of DOCK8-deficient CD4+ T cells to 50 
determine (1) intrinsic and extrinsic CD4+ T cell defects (2) how defects account for the clinical 51 
features of DOCK8 deficiency.   52 
Methods: We performed indepth analysis of the CD4+ T cell compartment of DOCK8-deficient 53 
patients. We enumerated subets of CD4+ T helper cells and assessed cytokine production and 54 
transcription factor expression. Finally, we determined the levels of IgE specific for staple 55 
foods and house dust mite allergens in DOCK8-deficient patients and normal controls. 56 
Results: DOCK8-deficient memory CD4+ T cells were biased towards a Th2 type, and this was 57 
at the expense of Th1 and Th17 cells. In vitro polarisation of DOCK8-deficient naive CD4+ T 58 
cells revealed the Th2 bias and Th17 defect to be T-cell intrinsic. Examination of allergen 59 
specific IgE revealed plasma IgE from DOCK8-deficient patients is directed against staple food 60 
antigens, but not house dust mites.  61 
Conclusion: Investigations into the DOCK8-deficient CD4+ T cells provided an explanation for 62 
some of the clinical signs of this disorder - the Th2 bias is likely to contribute to atopic disease, 63 
while defects in Th1 and Th17 cells compromise anti-viral and anti-fungal immunity, 64 
respectively explaining the infectious susceptibility of DOCK8-deficient patients.  65 
  66 
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KEY MESSAGES 67 
• DOCK8-deficient CD4+ T cells present with a Th2 cytokine bias, but also defects in 68 
Th1 and Th17 cells 69 
• The Th2 cytokine bias by DOCK8-deficient cells contributes to atopic disease such as 70 
eczema and food allergies in DOCK8 deficiency 71 
• Th17 cell defect is T cell intrinsic and contributes to compromised anti-fungal immunity 72 
in DOCK8-deficient patients. 73 
 74 
CAPSULE SUMMARY 75 
DOCK8-deficient CD4+ T cells exhibit dysregulated cytokine responses, with exaggerated 76 
production of Th2 cytokines, and impaired production of Th1 and Th17 cytokines. Collectively 77 
these findings provide explanations for some of the clinical features of DOCK8 deficiency, 78 
such as eczema and food allergies, and recurrent viral and microbial infections. 79 
 80 
KEYWORDS: Dedicator of cytokinesis 8, CD4+ T cell differentiation, Th2 skewing, allergy, 81 
atopic disease, chronic mucocutaneous candidiasis, viral immunity 82 
 83 
ABBREVIATIONS USED: 84 
AR-HIES: autosomal recessive hyper IgE syndrome 85 
BCG: Bacille Calmette-Guerin 86 
CMC: chronic mucocutaneous candidiasis 87 
CMV: cytomegalovirus 88 
DOCK8: Dedicator of cytokinesis 8 89 
EBV: Epstein-Barr virus 90 
HHV6: human herpes virus 6 91 
HPV: human papilloma virus 92 
HSCT: Hematopoietic stem cell transplant 93 
HSV: herpes simplex virus 94 
STAT: signal transducer and activator of transcription 95 
TAE: T cell activation and expansion  96 
TCM: central memory T cell 97 
TCR: T cell receptor 98 
TEM: effector memory T cell 99 
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Tfh: T follicular helper 100 
Tregs: regulatory T cells 101 
VZV: Varicella-zoster virus 102 
XLP: X-liked lymphoproliferative disease 103 
 104 
  105 
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INTRODUCTION 106 
Bi-allelic loss-of-function mutations in dedicator of cytokinesis 8 (DOCK8) cause a combined 107 
immunodeficiency also known as an autosomal recessive form of hyper IgE syndrome (AR-108 
HIES)1, 2. Affected patients typically present with recurrent Staphylococcus aureus skin 109 
infections, recurrent and severe cutaneous viral infections (HSV, HPV, Molluscum contagiosum 110 
virus), elevated serum IgE levels, lymphopenia, eosinophilia and an increased risk of 111 
malignancy1-3. DOCK8-deficient patients also exhibit impaired humoral immune responses 112 
against protein and polysaccharide antigens following natural infection or vaccination. 113 
Strikingly, DOCK8 deficiency predisposes most affected patients to developing asthma and 114 
severe allergies against food and environmental antigens1-5. However, the mechanisms 115 
underlying severe allergy are currently unknown.  116 
 117 
DOCK8 functions as a guanine nucleotide exchange factor to activate Rho-family GTPases 118 
such as CDC42, which mediate events including cell activation, division, survival, 119 
differentiation, adhesion, and migration6-8. Despite this, it is not immediately clear how DOCK8 120 
mutations result in the devastating immune abnormalities characteristic of patients with AR-121 
HIES. However, as DOCK8 is predominantly expressed by hematopoietic cells, it is likely to 122 
play critical lymphocyte-intrinsic roles in cellular and humoral immune responses against 123 
infectious diseases. Consistent with this, allogeneic hematopoietic stem cell transplant (HSCT) 124 
overcomes recurrent cutaneous viral infections, eczematous rash, and reduces IgE levels and 125 
eosinophilia9-14. In regards to food allergies in DOCK8 deficiency, some reports have 126 
documented improvement post-HSC 10, 11, 14, while others reported amelioration to symptoms13 127 
or no change9, 15.  128 
 129 
Ex vivo and in vitro analyses of lymphocytes from DOCK8-deficient patients have shed some 130 
light on disease pathogenesis. For instance, DOCK8-deficient patients have normal to increased 131 
numbers of total B cells but decreased circulating memory (CD27+) B cells5, 16. Functionally, 132 
compared with normal B cells, DOCK8-deficient B cells exhibit poor responses to the TLR9 133 
ligand CpG, while CD40-mediated responses were largely intact5. In B cells, DOCK8 acts as an 134 
adaptor protein connecting the TLR9-MYD88 pathway to STAT3 signalling, which is required 135 
for B cell proliferation and differentiation, as evidenced by defective function of STAT3-136 
deficient human B cells in vivo and in vitro17-20. These defects underlie poor humoral immunity 137 
in DOCK8-deficiency. Paradoxically, an increase in autoantibodies directed against nuclear, 138 
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cytoplasmic and extracellular matrix antigens has been detected in DOCK8-deficient patients, 139 
possibly due to decreased regulatory T cells (Tregs) in these patients21.  140 
 141 
Our previous study of T cells in DOCK8-deficient individuals revealed a severe reduction in 142 
naïve, central memory (CD45RA-CCR7+) and effector memory (CD45RA-CCR7-) CD8+ T 143 
cells but a marked accumulation of CD45RA+CCR7- terminally differentiated (i.e. “exhausted”) 144 
effector memory cells22. Strikingly, central and effector memory CD8+ T cells from DOCK8-145 
deficient individuals displayed phenotypic features of exhaustion, with increased expression of 146 
CD57, 2B4 and CD95, and accelerated loss of CD28 and CD127 (IL-7Rα)22. Furthermore, 147 
DOCK8-deficient naïve and memory CD8+ T cells failed to proliferate in vitro in response to T 148 
cell receptor (TCR) stimulation22. More recently, DOCK8-deficient CD8+ T cells were reported 149 
to undergo “cytothripsis”, a form of cell death associated with defects in morphology and 150 
trafficking that prevented the generation of long-lived resident memory CD8+ T cells in the skin 151 
and subsequently impaired immune responses to herpes virus infection at this site23. Taken 152 
together, these defects in CD8+ T cells provide a plausible explanation for viral susceptibility in 153 
DOCK8-deficient patients. DOCK8-deficient patients also have defects in the development of 154 
NKT cells and function of NK cells24, 25 which may contribute to increased susceptibility to 155 
viral infections and malignancies.  156 
 157 
In contrast to these established defects in B cells, Tregs, CD8+ T cells, NK cells and NKT cells, 158 
much less is known about the consequences of DOCK8 mutations in other human CD4+ T 159 
helper cells. While it has been reported that the frequencies of naïve and memory CD4+ T cells 160 
in DOCK8-deficient patients are normal, DOCK8-deficient naïve and memory CD4+ T cells do 161 
have a defect in TCR-induced proliferation, albeit less severe than DOCK8-deficient CD8+ T 162 
cells22. Consequently, this deficit is unlikely to cause clinical features such as atopic disease 163 
(dermatitis, severe food allergies) and increased IgE in DOCK8 deficiency. For this reason, we 164 
have undertaken a detailed analysis of the CD4+ T cell compartment in DOCK8-deficient 165 
patients. We found that DOCK8-deficient memory CD4+ T cells have a bias towards Th2 166 
cytokine expression (ie IL-4, IL-5, IL-13) and concomitant defective production of Th1 (IFNγ) 167 
and Th17 (IL-17A, IL-17F, IL-22) cytokines. Furthermore, the Th2 cytokine bias and impaired 168 
Th17 immunity, in the absence of DOCK8 were T cell intrinsic and independent of defects in 169 
proliferation. This intrinsic Th2 bias of DOCK8-deficient CD4+ T cells may underlie atopic 170 
disease and hyper-IgE displayed by DOCK8-deficient patients. Additionally, impaired Th1 and 171 
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Th17 responses likely account for impaired viral immunity and fungal infections such as 172 
chronic mucocutaneous candidiasis, respectively in DOCK8-deficient patients. 173 
 174 
METHODS 175 
Human samples 176 
PBMCs and/or plasma were isolated from normal donors (Australian Red Cross) and patients 177 
with DOCK8 deficiency (Table 1). The genotype of some of these patients has been previously 178 
reported1, 2, 15, 22, 24. All studies were approved by Institutional Human Research Ethics 179 
Committees and written informed consent was obtained from patients. 180 
 181 
Antibodies and Reagents 182 
Alexa488-anti-GATA3, Alexa647-anti-CXCR5, APC-Cy7-anti-CD4, BUV395-anti-IFNγ, 183 
BV711-anti-CD69, BV711-anti-IL-2, PE-anti-CCR6, PE-anti-CD95, Pe-Cy7-anti-CD25, and 184 
anti-mouse IgG1, and PerCpCy5.5-anti-CD127 and anti-Tbet were from Becton Dickinson. 185 
Alexa488-anti-IL-10, APC-anti-ICOS, eFluor660-anti-IL-21, FITC-anti-CD45RA, PE-IL-22, 186 
Pe-Cy7-anti-IL-4 and mouse IgG1 were from eBiosciences. APC-Cy7-anti-IL-17A, BV421-187 
anti-CXCR3, and BV605-anti-TNFα were from Biolegend. FITC-anti-CCR7 and recombinant 188 
human IL-12 was from R&D Systems. Anti-DOCK8 mAb was from Santa Cruz 189 
Biotechnology. Recombinant human TGFβ, IL-1β, IL-6, IL-21 and IL-23 were from Peprotech. 190 
Prostaglandin E2, PMA, calcium ionophore (ionomycin), Brefeldin A, and saponin were 191 
purchased from Sigma-Aldrich. Recombinant human IL-4 was provided by Dr Rene de Waal 192 
Malefyt (DNAX Research Institute, Palo Alto, CA). T cell activation and expansion (TAE) 193 
beads (anti-CD2/CD3/CD28) were purchased from Miltenyi Biotec and CFSE was purchased 194 
from Invitrogen. 195 
 196 
CD4+ T cell phenotyping  197 
To identify naïve, central memory (TCM) and effector memory (TEM) CD4+ T cell populations, 198 
PBMCs were incubated with mAbs to CD4, CCR7 and CD45RA and the frequency of 199 
CD4+CCR7+CD45RA+ (naïve), CD4+CCR7+CD45RA- (TCM), and CD4+CCR7-CD45RA- (TEM) 200 
populations determined by flow cytometry.  To identify CD4+ T cell populations, PBMCs were 201 
incubated with mAbs to CD4, CD25, CD127, CXCR5, CD45RA, CCR6 and CXCR3, and the 202 
frequency of Tregs (CD4+CD25hiCD127lo), Tfh (CD4+CD25loCD127hi CD45RA-CXCR5+), Th1 203 
(CD4+CD25loCD127hiCD45RA-CXCR5-CXCR3+CCR6-), Th2 (CD4+ CD25loCD127hiCD45RA-204 
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CXCR5-CXCR3-CCR6-) and Th17 (CD4+CD25loCD127hiCD45RA-CXCR5-CXCR3-CCR6+) 205 
subsets determined20.  206 
 207 
Analysis of cytokine expression/secretion by CD4+ and CD8+ T cells  208 
Naive and memory CD4+ T cells or naïve, memory and TEMRA CD8+ T cells22 were isolated by 209 
sorting on a FACS ARIA (Becton Dickinson; > 98% purity) and cultured with TAE beads (anti-210 
CD2/CD3/CD28) in 96 well round bottomed well plates. After 5 days, supernatants were 211 
harvested and production of IL-2, IL-4, IL-5, IL-6, IL-10, IL-13, IL-17A, IL-17F, IFNγ and 212 
TNFα determined by cytometric bead arrays (CBA; Becton Dickinson). For cytokine 213 
expression, activated T cells were re-stimulated with PMA (100 ng/ml) and ionomycin (750 214 
ng/ml) for 6 hours, with Brefeldin A (10 µg/ml) added after 2 hours. Cells were then fixed with 215 
formaldehyde and expression of IFNγ, IL-4, IL-17A, IL-22, IL-21, IL-10, TNFα and IL-2 216 
detected by intracellular staining20, 26-28. 217 
 218 
Analysis of transcription factor expression by CD4+ T cells 219 
Expression of Tbet and GATA3 protein was assessed by intracellular staining using a Fix/Perm 220 
kit from eBioscience. Expression of RORC was determined by QPCR28. 221 
 222 
Analysis of DOCK8 expression 223 
To determine intracellular DOCK8 expression, PBMCs were fixed with formaldehyde and 224 
stained with an unconjugated DOCK8 or an isotype control IgG1 mAb. PE-rat anti-mouse IgG1 225 
was then used with saponin as the permeablising agent29.  226 
 227 
Analysis of CD4+ T cell proliferation  228 
Naïve and memory CD4+ T cells were isolated by sorting and then labeled with CFSE. Their 229 
proliferation status was determined by assessing dilution of CFSE after 5 days of in vitro 230 
culture27, 28.  231 
 232 
In vitro Th1, Th2, Th17 cell differentiation 233 
Naive and memory CD4+ T cells were isolated by sorting and cultured under Th0 (TAE beads 234 
alone), or Th1 (50 ng/ml IL-12), Th2 (100 U/ml, IL-4) or Th17 (2.5 ng/mL TGFβ, 50 ng/mL 235 
IL-1β, 50 ng/mL IL-6, 50 ng/mL IL-21, 50 ng/mL IL-23, 50 ng/mL PGE2) polarising 236 
conditions. After 5 days cytokine secretion was analysed (CBA, intracellular staining)26, 28, 30. 237 
 238 
ImmunoCAP assay 239 
Plasma from normal donors and DOCK8-deficient patients was analysed for allergen specific 240 
M
AN
US
CR
IP
T
 
AC
CE
PT
ED
ACCEPTED MANUSCRIPT
Page 9 of 28 
IgE Abs by the Sydney South West Pathology Service (Royal Prince Alfred Hospital, Sydney 241 
Australia) using the Phadia 250 ImmunoCAP platform (Thermo Scientific). IgE specific for a 242 
staple food mix (FX5; egg white, milk, codfish, wheat, peanut and soyabean) or house dust mite 243 
mix was determined. 244 
 245 
Statistical analysis 246 
Significant differences were determined using either a Students t-test, multiple t-tests, one-way 247 
or two-way ANOVA (Prism; GraphPad Software). 248 
 249 
RESULTS 250 
Effects of DOCK8 deficiency on the generation of effector CD4+ T cell subsets in vivo.  251 
As an initial step in investigating CD4+ T cell function in the absence of DOCK8, we assessed 252 
the CD4+ T cell compartment to determine whether the generation and differentiation of CD4+ 253 
T cells was affected by DOCK8 deficiency and whether this could contribute to the combined 254 
immunodeficiency typical of these individuals. We previously investigated the peripheral T cell 255 
compartment in a small cohort (n = 6) of DOCK8-deficient patients22. We have now increased 256 
our cohort to comprise 18 individuals from 15 unrelated families and have extended our 257 
analysis to include additional surface markers to further distinguish different subsets within the 258 
CD4+ T cell population (Fig 1). Lack of DOCK8 expression in lymphocytes and monocytes 259 
from a representative healthy control, one unaffected sibling and 4 DOCK8-deficient patients is 260 
depicted in Supplementary Fig 1. Analysis of this larger cohort of DOCK8-deficient patients 261 
confirmed a statistically significant reduction in CD4+ T cells compared to normal donors (Fig 262 
1A). Naïve, central memory (TCM) and effector memory (TEM) CD4+ T cells can be resolved 263 
according to the differential expression of CD45RA and CCR731 (Fig 1B). This analysis 264 
revealed that the naïve and TCM compartments in DOCK8-deficient patients are comparable to 265 
normal individuals, but TEM CD4+ T cells were significantly increased in DOCK8-deficient 266 
patients (Fig 1C). Hence, despite the reduction in total CD4+ T cells, DOCK8-deficient CD4+ T 267 
cells differentiate normally into naïve and TCM cells; this is accompanied by a mild increase in 268 
TEM cells.  269 
 270 
Using a recently described gating strategy20, 32, we next examined the CD4+ T cell compartment 271 
for additional effector subsets: CD25hiCD127lo Tregs (Fig 1D, G)33, CXCR5+CD45RA- T 272 
follicular helper (Tfh) cells (Fig 1E, G), CD45RA-CXCR5- CXCR3+CCR6- Th1 (Fig 1F, G), 273 
CD45RA-CXCR5- CXCR3-CCR6- Th2 (Fig 1F, G), and CD45RA-CXCR5- CXCR3-CCR6+ 274 
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Th17 (Fig 1F, G) cells. DOCK8-deficient patients had an increased frequency of Tregs (Fig 275 
1D, G) but decreased frequency of Th17 cells (Fig 1F, G), while frequencies of Tfh, Th1 and 276 
Th2 cells according to this phenotypic delineation in patients were similar to normal donors 277 
(Fig 1D - G). Thus, there is a selective paucity of Th17 cells due to DOCK8 mutations. 278 
 279 
Assessment of expression of additional surface markers associated with CD4+ T cell 280 
differentiation indicated that the naïve, TCM and TEM CD4+ T cell populations from DOCK8-281 
deficient patients had undergone greater activation and terminal differentiation than 282 
corresponding CD4+ T cell subsets isolated from normal donors (Fig 1H-M). Specifically, the 283 
loss of expression of CD27 (Fig 1H), CD28 (Fig 1I) and CD127 (Fig 1J) and acquisition of 284 
CD57 (Fig 1K), CD95 (Fig 1L) and PD-1 (Fig 1M) by CD4+ TCM and TEM cells was 285 
exaggerated for DOCK8-deficient patients compared to controls. Collectively, DOCK8 286 
deficiency compromises the generation of Th17 cells, and results in the premature terminal 287 
differentiation of memory cells such that they acquire a senescent/exhausted phenotype. 288 
 289 
DOCK8 deficient memory CD4+ T cells are biased towards Th2 cytokines. 290 
Given the decrease in CCR6+CXCR3- cells – which are enriched for Th17-cytokine producing 291 
cells in healthy donors20, 34-36 – in DOCK8-deficient patients, we investigated cytokine 292 
expression by naïve and memory CD4+ T cells (Fig 2). Naïve and total memory (CD45RA-293 
CCR7+/-) CD4+ T cells were sort-purified from normal donors and DOCK8-deficient patients 294 
and then cultured with TAE beads conjugated to anti-CD2/CD3/CD28 mAbs for 5 days. After 295 
this time cells were restimulated with PMA/ionomycin and intracellular expression of IFNγ, IL-296 
4, IL-17A, IL-22, IL-21, IL-10, TNFα and IL-2 determined (Fig 2). Apart from IL-2 (Fig 2A) 297 
and TNFα (Fig 2B), which are expressed by 40-80% of normal naïve cells, only a small 298 
proportion of naïve cells (ie <5%) expressed any of the other cytokines examined. DOCK8-299 
deficient naïve CD4+ T cells expressed a comparable level of IL-2 (Fig 2A) and TNFα (Fig 2B) 300 
to that of normal naïve CD4+ T cells. However, analysis of the memory CD4+ T cell 301 
compartment in DOCK8-deficient patients revealed marked perturbations in differentiation in 302 
vivo. A significantly greater proportion of DOCK8-deficient memory CD4+ T cells expressed 303 
IL-4 compared to normal memory CD4+ T cells (Fig 2C), suggesting a skewing to the Th2 304 
effector lineage. Examination of mean fluorescence intensity of IL-4+ cells in DOCK8-deficient 305 
and normal memory CD4+ T cells revealed no significant differences (data not shown), 306 
suggesting there is an increase in the frequency of IL-4 expressing cells in the DOCK8 memory 307 
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CD4+ T cell compartment, but a comparable amount of IL-4 is produced per cell. The increase 308 
in IL-4+ cells in DOCK8-deficient memory CD4+ T cells was accompanied by significant 309 
reductions in expression of Th1 cytokines IFNγ (Fig 2D) and TNFα (Fig 2B), Th17 cytokines 310 
IL-17A (Fig 2E) and IL-22 (Fig 2F), and the Tfh cytokine IL-21 (Fig 2G). Expression of IL-10 311 
(Fig 2H) and IL-2 (Fig 2A) by memory CD4+ T cells was unaffected by DOCK8 deficiency.  312 
 313 
The Th2 skewing by DOCK8-deficient memory CD4+ T cells was also assessed by measuring 314 
cytokine secretion during the 5-day culture (Fig 3). This indicated concordance between 315 
expression and secretion of cytokines when assessed by intracellular staining and flow 316 
cytometry or cytometric bead array, respectively. Analysis of an extended panel of cytokines 317 
showed that DOCK8-deficient memory T cells secreted not only more IL-4 than normal 318 
memory CD4+ T cells, but also more of the Th2 cytokines IL-5 and IL-13 (Fig 3A-C) and less 319 
Th1 (IFNγ and TNFα; Fig 3D, E) and Th17 (IL-17A and IL-17F; Fig 3F, G) cytokines. 320 
Production of IL-6 (Fig 3H) was also significantly reduced. There were trends for less 321 
production of IL-10 and IL-2 by DOCK8-deficient memory CD4+ T cells, however these 322 
reduced values were not significant (Fig 3I, J). Production of TNFα and IL-2 by DOCK8-323 
deficient naïve CD4+ T cells was normal (Fig 3E, J). Taken together, memory CD4+ T cells 324 
from DOCK8-deficient patients display a Th2 bias, primarily expressing IL-4, IL-5 and IL-13 325 
and notably lower levels of cytokines characteristic of other T helper subsets. 326 
 327 
Th2 cytokine bias by DOCK8-deficient memory CD4+ T cells is independent of defects in cell 328 
proliferation. 329 
Previous work showed that lymphocyte differentiation eg Ig class switching and antibody 330 
secretion by naïve B cells, and cytokine production and cell surface phenotype expression by 331 
naïve T cells, is regulated by cell division27, 37-39. DOCK8-deficient naïve (Fig 3K) and memory 332 
(Fig 3L) CD4+ T cells were found to have impaired cell division in vitro, consistent with 333 
previous findings22. Thus, it was possible that the perturbed cytokine profile reflected reduced 334 
proliferation by DOCK8-deficient memory CD4+ T cells. However, the Th2 bias of DOCK8-335 
deficient memory CD4+ T cells was not due to a proliferative defect as evidenced by two 336 
important and related findings. First, when memory cells were isolated and restimulated 337 
immediately for analysis of cytokine expression, the preferential production of IL-4 by 338 
DOCK8-deficient over normal memory CD4+ T cells was still observed in the absence of cell 339 
proliferation (Fig 3M). Similarly, the poor production of Th1 and Th17 cytokines by DOCK8-340 
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deficient memory CD4+ T cells did not result from impaired proliferation because reductions in 341 
expression of IFNγ (normal: 17.7%, DOCK8: 6.9%) and IL-22 (normal: 3.7%, DOCK8: 1.8%) 342 
respectively were also observed when assessed under these ex vivo stimulatory conditions. 343 
Second, analysis of cells that had undergone different rounds of divisions in vitro revealed that 344 
the decrease in IFNγ (Fig 3N) and increase in IL-4 (Fig 3O) displayed by DOCK8-deficient 345 
versus normal memory CD4+ T cells was evident for all division intervals examined. Thus, the 346 
preference of DOCK8-deficient memory CD4+ T cells to produce Th2, but not Th1, cytokines 347 
is independent of any proliferative defects in these cells.  348 
 349 
Naive DOCK8-deficient CD4+ T cells can differentiate into effector cells producing Th1 and 350 
Th2, but not Th17, cytokines in vitro. 351 
To determine if the defects in cytokine production by DOCK8-deficient memory CD4+ T cells 352 
are cell-intrinsic or due to extrinsic factors, we isolated naïve CD4+ T cells from normal donors 353 
and DOCK8-deficient patients and subjected them to in vitro culture under Th0, Th1, Th2 or 354 
Th17 polarising conditions. Interestingly, DOCK8-deficient naïve CD4+ T cells differentiated 355 
into Th1 cells (IFNγ and TNFα) to the same extent as normal naïve CD4+ T cells (Fig 4A, left 356 
panel). Consistent with the data for memory CD4+ T cells ex vivo, DOCK8-deficient naïve 357 
CD4+ T cells produced significantly greater amounts of the Th2 cytokine IL-13 than control 358 
naïve CD4+ T cells under Th2-polarising conditions (3-fold increase; Fig 4A, middle panels). 359 
We also analysed Th2 differentiation by assessing cytokine expression in naïve CD4+ T cells by 360 
intracellular staining and flow cytometry following in vitro Th2 polarization. This confirmed a 361 
preferential differentiation of DOCK8-deficient towards a Th2 fate, with increased proportions 362 
of DOCK8-deficient naïve CD4+ T cells expressing IL-4 (9.9% DOCK8-deficient vs 5.5% 363 
control CD4+ T cells) and IL-13 (5.9% DOCK8-deficient vs 1.7% control CD4+ T cells). 364 
Together, these data provide evidence of a predominant intrinsic bias of DOCK8-deficient 365 
naïve CD4+ T cells differentiating towards a Th2 effector fate. DOCK8-deficient naïve CD4+ T 366 
cells failed to differentiate into IL-17A- and IL-17F-secreting cells when subjected to Th17 367 
polarising conditions in vitro (Fig 4A, right panels). Notably, DOCK8-deficient naïve CD4+ T 368 
cells responded to the Th17 culture as shown by reductions in basal levels of IL-5 and IL-13 369 
secretion compared to the Th0 culture (data not shown).  370 
 371 
When we examined memory CD4+ T cells from healthy donors, production of IFNγ and IL-372 
17A/F could be increased ~2-4 fold by Th1 and Th17 culture conditions, respectively, 373 
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compared to Th0 conditions (Fig 4B). The net increase in production of these cytokines by 374 
DOCK8-deficient memory CD4+ T cells under Th1 and Th17 conditions compared to Th0 375 
conditions was also ~2-6 fold. Despite this, the levels of IFNγ and IL-17A/F secreted by Th1- 376 
and Th17-stimulated DOCK8-deficient memory CD4+ T cells were substantially less than not 377 
only Th1- and Th17-stimulated normal memory CD4+ T cells, but also Th0-stimulated normal 378 
memory CD4+ T cells (Fig 4B). This likely reflects expansion of the few Th1 and Th17 cells 379 
present in the DOCK8 memory CD4+ T cell compartment rather than de novo differentiation 380 
into these effector subsets in vitro.  381 
 382 
Consistent with the data for cytokine secretion, DOCK8-deficient naïve CD4+ T cells that were 383 
polarised towards Th1 and Th2 fates upregulated TBET (Fig 4C) and GATA3 (Fig 4D), 384 
respectively, to the same extent as normal naïve CD4+ T cells. In our hands, detection of RORγt 385 
expression by flow cytometry was not particularly sensitive, as we found that only a small 386 
proportion of naïve CD4+ T cells (~5%) expressed RORγt in Th17 compared to Th0 activated 387 
cultures40. To overcome this, RORC expression was determined by QPCR. RORC was not 388 
expressed by naive CD4+ T cells activated under Th0 conditions, but was up-regulated in 389 
normal and DOCK8-deficient naïve CD4+ T cells cultured under Th17 polarising conditions 390 
(Fig 4E). Taken together, these data indicate the Th17 cytokine defect in DOCK8 deficiency is 391 
T cell intrinsic, and cannot be restored by Th17 polarising conditions for either naïve or 392 
memory cells. Furthermore, the ability of Th17 culture conditions to induce RORC in the 393 
absence of DOCK8 indicates the defect in Th17 differentiation is downstream of RORC. In 394 
contrast, DOCK8-deficient naïve CD4+ T cells differentiate normally into Th1 cells, and exhibit 395 
exaggerated Th2 differentiation, when provided with the appropriate stimuli in vitro. 396 
 397 
Preferential production of Th2 cytokines by DOCK8-deficient CD4+ T cells correlates with 398 
reduced TCR-mediated activation 399 
The strength of signal provided to CD4+ T cells through the TCR greatly influences their 400 
differentiation to cytokine-producing effector cells. For instance, reduced signal strength 401 
favours Th2 cells41-44, while differentiation to Th17 cells requires stronger or sustained TCR 402 
signalling45, 46. Our findings of heightened production of Th2 cytokines by DOCK8-deficient 403 
naïve and memory CD4+ T cells led us to hypothesise that mutations in DOCK8 compromised 404 
TCR signal strength. To assess this, we cultured DOCK8-deficient CD4+ T cells with differing 405 
doses of anti-CD2/CD3/CD28 beads for 3 days and then measured levels of expression of the 406 
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activation molecules ICOS, CD25, CD69, and CD95. The rationale here is that lowering the 407 
dose of the beads results in a qualitatively weaker signal. While CD4+ T cells from healthy 408 
controls exhibited heightened expression of ICOS, CD69, CD25 at the 2 different doses of anti-409 
CD2/CD3/CD28 beads tested, induction of these same molecules on DOCK8-deficient CD4+ T 410 
cells was severely blunted (Fig 4F). Thus, mutations in DOCK8 compromise T cell activation 411 
by reducing the strength of signal delivered through the TCR and co-stimulatory receptor 412 
signaling pathways. In the case of T cell differentiation, this results in a skewing of the cells 413 
towards a Th2 phenotype.  414 
 415 
Specific sensitisation of DOCK8-deficient patients to food allergens 416 
Exaggerated Th2 immune responses have traditionally been associated with allergy and atopic 417 
disease47. It was thus intriguing to note that CD4+ T cells from DOCK8-deficient patients were 418 
biased towards production of Th2 cytokines, and that these patients have severe allergies. To 419 
determine if the Th2 bias in DOCK8-deficient human CD4+ T cells is related to their increased 420 
susceptibility to food allergies we examined the specificity of IgE in serum samples from 421 
DOCK8-deficient patients and normal healthy donors to staple foods (i.e. egg white, milk, 422 
codfish, wheat, peanut, soyabean), as well as to non-food allergens such as house dust mites. 423 
We found that a comparable frequency of normal individuals and DOCK8-deficient patients 424 
had IgE specific to house dust mites (Fig 5A). Strikingly, the majority of plasma samples from 425 
DOCK8-deficient patients (80%; 12/15), but none of the normal controls tested, had IgE that 426 
was specific for the staple food mix (Fig 5B). Thus, DOCK8-deficient patients have a Th2 bias 427 
that manifest clinically as specific sensitisation to oral allergens and this may explain the 428 
marked propensity of these immunodeficient patients to develop food allergies. 429 
 430 
DISCUSSION 431 
Identifying defects in lymphocyte development or function in PIDs provides the opportunity to 432 
elucidate the cellular and molecular basis for the clinical features of the disease. Studies of 433 
DOCK8-deficient humans and mice have indeed revealed critical cell-intrinsic roles for 434 
DOCK8 in generating B-cell memory and long-lived humoral immunity5, 48, CD8+ T cell 435 
differentiation and anti-viral responses22, 23, 49, 50, NK cell cytotoxicity24 and NKT cell 436 
development25. Collectively, these defects underlie poor Ab responses to specific Ags, and 437 
impaired cell-mediated immunity to pathogens including HSV, HPV and Molluscum 438 
contagiosum virus. We have now investigated CD4+ T cell differentiation in DOCK8-deficient 439 
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patients to understand other aspects of AR-HIES, such as susceptibility to bacterial and fungal 440 
infections, atopic disease, food allergies and hyper-IgE.  441 
 442 
Our data revealed that DOCK8-deficient CD4+ T cells have dysregulated expression of surface 443 
molecules including CD27, CD57, CD95 and PD-1. This likely results from chronic infection 444 
with pathogens, such as herpes viruses (HSV, CMV, VZV), HPV and Molluscum contagiosum 445 
virus, akin to what has been described for CD8+ T cells in not only DOCK8 deficiency22, but 446 
other PIDs such as XLP51, 52, STAT3 deficiency53 and PIK3CD gain of function mutations54, 447 
which are characterised by chronic exposure to infectious pathogens. In the absence of DOCK8, 448 
memory CD4+ T cells are polarised to a Th2 cytokine phenotype at the expense of Th1 and 449 
Th17 cytokines. The reduction in Th17 cells was apparent not only from the lack of cells 450 
producing IL-17A, IL-17F and IL-22, but also the reduction in CCR6+ memory CD4+ T cells. 451 
This is consistent with our previous studies which revealed parallel reductions in CD4+ T cells 452 
secreting IL-17A/IL-17F and expressing CCR6+ in patients with STAT3 loss-of function or 453 
STAT1gain-of function mutations17, 20, 28, indicating that flow cytometric analysis of CCR6+ 454 
memory CD4+ T cells can be a reliable and rapid means of quantifying Th17 cells. 455 
Interestingly, DOCK8-deficient naïve CD4+ T cells differentiated into TBET-expressing and 456 
Th1-cytokine secreting cells when provided with exogenous signals in vitro. This suggests that 457 
defects in IFNγ production by DOCK8-deficient memory CD4+ T cells ex vivo are extrinsic, 458 
possibly resulting from suboptimal priming by Ag-presenting cells and provision of IL-12 in 459 
vivo. Consistent with this, DOCK8-deficient murine DCs failed to accumulate in the lymph 460 
node parenchyma where they are required for T cell priming during immune responses55. This 461 
defect was attributed to compromised Cdc42 function in the absence of DOCK855. Another 462 
possibility is that excessive production of IL-4, which restrains differentiation of human CD4+ 463 
T cells into Th1 cells56, impairs IFNγ production by DOCK8-deficient memory CD4+ T cells. 464 
This is consistent with our recent observations of heightened production of Th2 cytokines and 465 
corresponding reductions in IFNγ production ex vivo by memory CD4+ T cells from individuals 466 
with loss-of function mutations in STAT3, IL21R, IL12RB1, TYK2 or RORC20, 57. While 467 
DOCK8-deficient naïve CD4+ T cells could express RORC in vitro following activation under 468 
Th17-polarisng conditions, IL-17A/F cytokine secretion remained greatly impaired. Thus, an 469 
intrinsic defect distal to inducing RORC expression underlies the inability of DOCK8-deficient 470 
CD4+ T cells to become Th17 cells. Although Th1- and Th17-polarising conditions did increase 471 
IFNγ and IL-17A/F production by DOCK8-deficient memory CD4+ T cells, these cells 472 
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produced lower levels of these cytokines than normal cells under similar culture conditions. 473 
Interestingly, CD4+ T cells from DOCK8-deficient mice expressed normal levels of TBET and 474 
GATA3 when activated under Th1 and Th2 polarising conditions, respectively, in vitro49. 475 
Interestingly, while IFNγ expression by in vitro-derived murine DOCK8-deficient Th1 cells 476 
was normal, Th2 polarised DOCK8-deficient CD4+ T cells showed increases in IL-4-expressing 477 
cells49, suggesting that murine DOCK8 deficient CD4+ T cells also display a Th2 bias.  478 
 479 
These findings provide potential explanations for some of the clinical features of DOCK8 480 
deficiency. First, lack of Th17 cells would predispose DOCK8-deficient individuals to 481 
infections with Candida albicans. This is akin to other monogenic PIDs characterised by 482 
impaired Th17/IL-17-mediated immunity and the high incidence of chronic mucocutaneous 483 
candidiasis (CMC) in affected individuals ie loss-of-function mutations in STAT3, IL17RA, 484 
IL17RC, IL17F, ACT1 and RORC, and gain-of-function mutations in STAT120, 28, 57-62. 485 
Compared to other PIDs with defects in Th17 cytokines, IL-17A/IL-17F production by 486 
DOCK8-deficient memory CD4+ T was less than that observed for RORC- or STAT3-deficient 487 
memory CD4+ T cells20, 57. Remarkably, the quantitative impact of specific gene mutations on 488 
generating Th17 cells correlates with, or predicts, the incidence of fungal infections in these 489 
individuals. Thus, ~85% of patients with mutations in STAT3 or RORC develop CMC 57, 63, but 490 
fungal infections is observed in only ~40-60% of DOCK8-deficient patients, as shown for the 491 
cohort studied here (Table 1), and in a larger study of 57 patients64. Thus, there is likely a direct 492 
association between IL-17A/IL-17F production in different PID patients and incidence of 493 
CMC. Second, the predominance of memory CD4+ T cells producing high levels of IL-4, IL-5 494 
and IL-13 could contribute to the characteristic pathophysiological Th2 features of AR-HIES: 495 
severe allergy, eosinophilia and hyper-IgE65. This exaggerated Th2 response may also reduce 496 
Th17 differentiation66, further compromising Th17-mediated anti-fungal immune responses. 497 
Although memory CD4+ T cells displayed reduced IFNγ production ex vivo, DOCK8-deficient 498 
naïve CD4+ T cells could differentiate into Th1 cells in vitro. Thus, Th1-mediated immunity, 499 
while reduced, may be sufficient in these individuals to elicit protective immunity. Indeed, this 500 
is consistent with a lack of disease caused by poorly virulent mycobacteria, such as BCG 501 
vaccines and environmental species - which require IFNγ-mediated immunity for protection67 - 502 
in DOCK8 deficiency. In the scenario of anti-viral immunity, the increased Th2-cytokine 503 
environment within the memory CD4+ T cell compartment may inhibit IFNγ production by 504 
CD8+ T cells. Indeed, analysis of DOCK8-deficient memory CD8+ T cells ex vivo revealed 505 
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defective IFNγ expression and secretion compared to healthy donors (Supplementary Fig 2A, 506 
B)1. Thus, by diminishing Th1 responses, a Th2 bias could contribute to persistent viral 507 
infections in DOCK8-deficient patients. Third, beyond Th1, Th2 and Th17 cytokines, we also 508 
noted reduced production of IL-6 by DOCK8-deficient memory CD4+ T cells. While there have 509 
been no genetic studies linking impaired IL-6 production with infection with specific 510 
pathogens, autoantibodies against IL-6 were reported in an individual with recurrent 511 
staphylococcal infection 68. Thus it is possible that poor IL-6-mediated immunity in DOCK8 512 
deficiency underlies staphylococcal infection in affected patients. Fourth, while previous work 513 
demonstrated that DOCK8 functions intrinsically in B cells to regulate differentiation, reduced 514 
production of IL-21 (and potentially IL-10) by DOCK8-deficient memory CD4+ T cells may 515 
also contribute to impaired humoral immune responses in AR-HIES, as these cytokines are the 516 
main drivers of human B cell activation, proliferation and differentiation69. This is supported by 517 
our observation that DOCK8-deficient memory CD4+ T cells present with defects in IL-21 518 
expression ex vivo (Figure 2) and naïve DOCK8-deficient CD4+ T cells failed to differentiate 519 
into IL-21+ cells as efficiently as normal naïve CD4+ T cells when cultured under Tfh cell 520 
polarising conditions (Supplementary Fig 2C). 521 
 522 
A characteristic and perhaps unique feature of DOCK8 deficiency compared to other PIDs 523 
(including those in which there are high levels of IgE such as mutations in STAT3) is the very 524 
high incidence of food allergies1-5. The allergen-specific IgE from DOCK8-deficient patients 525 
was directed mostly towards staple foods rather than non-food allergens such as house dust 526 
mites. This is consistent with a recent report which showed that this pattern of allergen-specific 527 
IgE is unique to DOCK8 deficiency70, inasmuch that DOCK8 deficient patients had IgE 528 
directed towards food Ags, while patients with atopic dermatitis have IgE specific for 529 
aeroallergens, yet the reactivity of IgE in STAT3-deficient individuals against specific allergens 530 
was comparable to normal donors70. Since food allergies are more common in children who 531 
often outgrow them once they reach adolescence, IgE sensitisation to food Ags and not house 532 
dust mites in DOCK8 deficiency could be attributable to the younger age of our DOCK8 cohort 533 
compared to our normal controls. However, this is unlikely as 9 of the 12 DOCK8 deficient 534 
patients that still had IgE specific to food Ags were adolescents or adults. In the scenario of 535 
STAT3 deficiency, the reduced level of IgE specific for food allergens when compared to 536 
patients with atopic dermatitis has been attributed to a defect in basophil activation and mast 537 
cell degranulation, with the latter process found to be STAT3-dependent71. This is interesting 538 
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because although patients with mutations in DOCK8 or STAT3, or individuals with atopic 539 
dermatitis, all display increased serum IgE, eczema and atopic disease, DOCK8 deficiency 540 
specifically predisposes to food allergies. The mechanism whereby this occurs is unclear, but it 541 
is tempting to speculate that it is related to the Th2 bias of DOCK8-deficient memory CD4+ T 542 
cells. While Th2 skewing has been reported in DOCK8-deficient mice in vitro49, to our 543 
knowledge, IgE responses following exposure to food allergens have not been investigated in 544 
mice, but may provide invaluable insights into whether exposure to food allergens is the driver 545 
of IgE production in DOCK8 deficiency. Nevertheless, our findings reinforce the value of 546 
direct interrogation of patient cells and highlight the need to be cognisant of species-specific 547 
differences that impact translation of murine studies to humans. 548 
 549 
The underlying cause for the biased Th2 nature of memory CD4+ T cells in DOCK8-deficient 550 
patients remains to be determined. Examination of the TCR Vβ repertoire in the CD4+ T cell 551 
compartment of DOCK8 deficient patients and healthy normal donors did not reveal any 552 
substantial differences (data not shown). However, there is evidence showing that the strength 553 
of the signal received through the TCR greatly influences differentiation of CD4+ T cells. 554 
Specifically, low doses of Ag/low level TCR signalling favour humoral or IL-4-mediated Th2 555 
immune responses while high doses of Ag/strong TCR signalling favour cellular or IFNγ-556 
mediated Th1 immune responses41-43. This is also supported genetically, as murine CD4+ T 557 
cells with a hypomorphic Card11 mutation reduces TCR-mediated signal strength resulting in 558 
exaggerated Th2 differentiation, allergic disease, dermatitis and hyper-IgE44. Based on this, we 559 
hypothesise that DOCK8-deficient CD4+ T cells receive a qualitatively weaker TCR signal, 560 
potential due to defective immunological synapse formation48, which favors their preferential 561 
differentiation into Th2 cells at the expense of other Th cell subsets. Our data demonstrating 562 
reduced induction of expression of activation markers on DOCK8-deficient CD4+ T cells in 563 
response to increasing doses of anti-CD2/CD3/CD28 bead stimulation supports this hypothesis. 564 
The original studies on strength of TCR signals influencing murine Th cell differentiation 565 
predated the discovery of Th17 cells. However, studies in mice and humans have since 566 
demonstrated a requirement for sustained TCR signalling in naïve T cells for commitment to a 567 
Th17 phenotype in vitro and in vivo45, 46. Thus, we would predict that reduced TCR signal 568 
strength in DOCK8-deficient CD4+ T cells impairs their differentiation into Th17 cells. 569 
 570 
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In conclusion we reveal that the CD4+ T cell compartment is greatly altered in the absence of 571 
DOCK8. Specifically, DOCK8-deficient patients have increased Th2 cells and defects in Th1 572 
and Th17 cell differentiation. This skewing of CD4+ T cell subsets likely accounts for some of 573 
the clinical manifestations in DOCK8-deficient individuals. Strikingly, within our DOCK8 574 
cohort, all the patients investigated had IgE that was specific for at least one of the following 575 
foods - egg white, milk, codfish, wheat, peanut and soyabean-, but not non-food allergens. 576 
These results indicate that the detection of high titers of IgE specific for food but not to other 577 
allergens is predictive of DOCK8 deficiency. Thus, future studies to identify signalling 578 
pathways and cellular processes affected by DOCK8 deficiency in CD4+ T cells will not only 579 
improve our understanding of disease pathogenesis in affected DOCK8-deficient individuals, 580 
but also patients with atopic disease. 581 
  582 
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FIGURES LEGENDS 596 
Figure 1: Phenotype of the peripheral CD4+ T cell compartment in DOCK8-deficient 597 
patients. (A) The frequency of CD4+ T cells in normal donors and DOCK8-deficient patients. 598 
(B, C) Naïve (CD45RA+CCR7+), central memory (TCM; CD45RA-CCR7+) and effector 599 
memory (TEM; CD45RA-CCR7-) populations in normal donors (closed symbol; n = 25) and 600 
DOCK8-deficient patients (open symbol; n = 18) were enumerated based on expression of 601 
CD45RA and CCR7. (D-G) PBMCs were labelled with mAbs against CD4, CD45RA, CD25, 602 
CD127, CXCR5, CXCR3 and CCR6. (D) Treg cells were identified as CD25hiCD127lo. (E) 603 
Amongst the non-Treg population naïve and Tfh cells were identified as CXCR5-CD45RA+ and 604 
CXCR5+CD45RA-, respectively. (F) Th1, Th2 and Th17 populations were identified within the 605 
population of CXCR5-CD45RA- memory CD4+ T cells as CXCR3+ CCR6-, CCR6-CXCR3- and 606 
CCR6+CXCR3- cells, respectively. (G) Using this gating the frequency of Tregs, Tfh, Th1, Th2 607 
and Th17 cells within the CD4+ T cell compartment was determined in normal individuals 608 
(closed symbol; n = 15 or 16) and in DOCK8-deficient patients (open symbol; n = 10 or 11). 609 
Each point represents an individual donor or patient. Statistics performed with Prism using 610 
Student t-test. (H-M) Naïve (CD45RA+CCR7+), central memory (TCM; CD45RA-CCR7+) and 611 
effector memory (TEM; CD45RA-CCR7-) populations in normal donors (closed symbol) and 612 
DOCK8-deficient patients (open symbol) were identified and assessed for expression of (H) 613 
CD27, (I) CD28, (J) CD127, (K) CD57, (L) CD95 and (M) PD1. Each point corresponds to the 614 
mean ± SEM % of cells expressing the indicated surface receptor, or MFI (mean fluorescence 615 
intensity) of expression (n = 4 - 12 normal donors or DOCK8-deficient individuals). Statistics 616 
performed with Prism using t-test. 617 
 618 
Figure 2: DOCK8-deficient memory CD4+ T cells display a Th2 cytokine expression bias. 619 
Naïve (CD45RA+CCR7+) and memory (CD45RA-CCR7+/-) CD4+ T cells were isolated from 620 
normal donors and DOCK8-deficient patients and cultured with TAE beads for 5 days. Cells 621 
were then re-stimulated with PMA/ionomycin for 6 hours in the presence of Brefeldin A for the 622 
last 4 hours. Intracellular expression of (A) , (B) TNFα, (C) IL-4, (D) IFNγ, (E) IL-623 
17A, (F) IL-22, (G) IL-21 and (H) IL-10 was determined using saponin as the permeabilising 624 
agent followed by flow cytometric analysis. Data represent the mean ± SEM of 8 normal 625 
donors or 8 DOCK8-deficient patients. Statistics performed with Prism using One-way 626 
ANOVA.  627 
 628 
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Figure 3: DOCK8-deficient memory CD4+ T cells secrete elevated quantities of the Th2 629 
cytokines IL-4, IL-5 and IL-13 independently of differences in cell proliferation. Naïve and 630 
memory CD4+ T cells were sorted from normal donors and DOCK8-deficient patients and 631 
cultured with TAE beads for 5 days. After this time, culture supernatants were examined for 632 
secretion of (A) IL-4  (B) IL-5, (C) IL-13, (D) IFNγ, (E) TNF, (F) IL-17A, (G) IL-17F, (H) IL-633 
6, (I) IL-10, (J) IL-2, using a custom designed cytometric bead array (CBA; BD biosciences). 634 
Data represent the mean ± SEM of experiments using cells from 9 normal donors or DOCK8-635 
deficient patients. Statistics performed with Prism using One-way ANOVA. (K-L) Naive (K) 636 
and memory (L) CD4+ T cells were isolated from normal donors (n = 4) and DOCK8-deficient 637 
patients (n = 4), labelled with CFSE and cultured with TAE beads for 5 days. After this time, 638 
the frequency of cells in each division was determined by dilution of CFSE. (M) Sorted naïve 639 
and memory CD4+ were immediately restimulated with PMA/ionomycin for 6 hours in the 640 
presence of Brefeldin A and IL-4 expression determined by intracellular staining and flow 641 
cytometry. (N, O) Naive and memory CD4+ T cells were labelled with CFSE, cultured with 642 
TAE beads for 5 days, and the proportion of cells expressing (L) IFNγ  or (M) IL-4 was 643 
determined for each division interval by dilution of CFSE. Data represent the mean ± SEM of 2 644 
- 4 normal donors and DOCK8-deficient patients.  645 
 646 
Figure 4: Intrinsic defects in CD4+ T cell cytokine secretion due to DOCK8 mutations. (A) 647 
Naïve and (B) memory CD4+ T cells were isolated from normal donors and DOCK8-deficient 648 
patients and activated under neutral conditions (Th0; TAE only), or Th1- (+ IL-12), Th2- (+ IL-649 
4), or Th17- (+ IL-1β, IL-6, IL-21, IL-23, TGFβ, PG) polarising conditions. After 5 days, 650 
secretion of Th1 (IFNγ), Th2 (IL-5, IL-13) and Th17 (IL-17A, IL-17F) cytokines was 651 
determined by CBA. The data represent the mean ± SEM of experiments using cells from 12 652 
normal donors and 8 DOCK8-deficient patients. Expression of (C) TBET and (D) GATA3 was 653 
determined by flow cytometry; the data represent the fold change (mean ± sem) in expression 654 
of the indicated transcription factor relative to Th0 culture of the normal control. (E) expression 655 
of RORC was determined by QPCR. Data represent the mean and SEM of 2 - 3 normal donors 656 
and DOCK8-deficient patients. (F) Memory CD4+ T cells from healthy donors or DOCK8-657 
deficient patients (n=2) were cultured with TAE beads at a cell:bead ratio of 2:1 and 0.5:1, and 658 
expression of ICOS, CD25, CD69 and CD95 was determined prior to culture (day 0) and 3 days 659 
after activation. The values represent the mean ± sem of the MFI of each of the indicated 660 
surface receptors. Statistics performed with Prism using two-way ANOVA. 661 
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 662 
Figure 5: IgE in DOCK8 deficient patients is specific for staple foods and not other Ags 663 
such as house dust mites. 664 
Plasma from normal donors and DOCK8-deficient patients was analysed for IgE specific for 665 
(A) a staple food mix (egg white, milk, codfish, wheat, peanut and soyabean) and (B) a house 666 
dust mite mix by ImmunoCAP. The data represent the mean ± SEM of 13 normal donors and 667 
15 DOCK8-deficient patients. The dotted line refers to the upper limit of the negative reference 668 
interval (0.35 kUA/L). 669 
 670 
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Table 1: DOCK8 deficient patients 
DOCK8-
deficient 
patients 
 
Mutation Gender Age 
at 
study 
IgE 
(IU/ml) 
Allergies/atopic disease Infections Other 
#1 
 
Homozygous 
114 kb deletion 
spanning exons 
4 - 26 
female 14 4,864 – 
10,000 
- No known allergies 
- Eczema 
- Hypereosinophilia 
without lymphopenia 
Pneumonia, cutaneous 
lesions and abscesses, 
fungal infections, 
lymphadenitis, cheilitis,  
Chrysosporium parvum. 
Chronic diarrhea, rectal 
prolapse, bronchiectasis, 
tolerated BCG vaccine. 
Deceased. 
#2 Homoz A->T; 
position 70 exon 
7; K271X 
female 12 10,000 - No known allergies 
-  Eczema 
Severe M. contagiosum, 
pneumonia, meningitis. 
 
#3 Homozygous 
400 kb deletion 
(totality of 
DOCK8 + 5’ of 
KANK1) 
female 12 >5,000 - Multiple food, 
environmental, and drug 
allergies 
- Severe eczema 
(lichenification) 
- Hypereosinophilia 
(>3000/mm3) 
Stomatitis, M. 
contagiosum, 
respiratory syncytial 
virus, HSV1, Candida 
sp, H. influenza, 
P. jirovecii. 
Abdominal vasculitis, 
lymphadenopathy, 
splenomegaly, CD3+ 
lymphopenia. Successful 
HSCT. 
#4 Homozygous 
114 kb deletion 
spanning exons 
4 - 26 
male 10 1,552 - No known allergies 
- Eczema 
- Hypereosinophilia 
(7800/mm3). 
Recurrent otitis media, 
herpes labialis, HPV, 
disseminated plain warts, 
onychomycosis, 
Salmonella sp. 
 
Arthritis, uveitis, 
interstitial lung disease, 
inflammatory bowel 
disease, mesenteric 
vasculitis. Tolerated BCG 
vaccine. Deceased. 
#5 Homozygous 
114 kb deletion 
spanning exons 
4 - 26 
female 12 19,302 - No known allergies 
- Eosinophilia 
(5,000/mm3). 
Recurrent upper 
respiratory tract 
infection, HPV, flat 
warts, herpetic stomatitis, 
Giardia lamblia, 
Salmonella enterica, E. 
coli. 
Uncomplicated 
chickenpox. Inflammatory 
bowel disease, abdominal 
vasculitis, thrombocytosis. 
Tolerated BCG vaccine. 
Deceased. 
#6 c.3733_3734del
AG; 
male 12 1,500 - Multiple food allergies 
(egg, cow’s milk) 
Methicillin-resistant S. 
aureus infection, M. 
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p.R1245EfsX5 - Peanut sensitised 
(tolerant) 
- Environmental allergies 
(house dust mite, rye 
grass, bermuda grass). 
Previous allergic rhinitis 
- Infrequent episodic 
asthma (viral induced) in 
childhood 
-  Eczema 
contagiosum, recurrent 
otitis media. 
#7  Homozygous 
deletion 9p24.3 
323,819-
324,708 
female 8 9,196 - Food allergies 
- Diffuse colonic and 
esophageal eosinophilia 
- Eczema 
- Asthma 
CMV, BK virus, chronic 
Salmonella, recurrent 
sinopulmonary 
infections, skin 
abscesses. 
Sclerosing cholangitis. 
#8  heterozygous 
deletions 
involving exons 
22-25 and 3-32 
female 14 6,270 - Food allergies 
- Environmental allergies  
- Rhinitis  
- Asthma 
- Allergic conjunctivitis 
- Eczema  
HPV, M. contagiosum, 
meningitis, bacteremia, 
fungal skin infections.  
Vasculopathy. Allergic 
symptoms improved after 
transplant. 
 
#9 • Large 
heterozygous . 
deletion 
(~200kb)  
• 2bp 
heterozygous 
deletion in exon 
41 (c.5307-5308 
del AC, 
pL1770fsX1783 
female 7 >6,000 - No known allergies 
- Severe eczema 
(lichenification) 
-  Eosinophilia 
(>3,000/m3) 
Skin abscesses, M. 
contagiosum, recurrent 
respiratory tract 
infection, chronic otitis, 
maxillary sinusitis, 
bronchiectasis, HPV 
warts, HSV, H. influenza, 
Salmonella spp. 
 IgG,  IgM, IgA,  
CD4+ lymphopenia. 
#10 • Large 
heterozygous . 
deletion 
(~200kb)  
male 10 >4,400 - No known allergies 
- Moderate eczema 
- Eosinophilia 
Skin abscess, M. 
contagiosum, recurrent 
upper respiratory tract 
infection, HPV 
 IgG,  IgM,  IgA, 
CD4+ lymphopenia. 
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• 2bp 
heterozygous 
deletion in exon 
41 (c.5307-5308 
del AC, 
pL1770fsX1783 
disseminated warts, HSV 
stomatitis, S. aureus, S. 
pyrogenes. 
#11 heterozygous 
large deletions 
one deletion 
involving the 
two gene copies 
of 80kb in 5’ 
part of the gene 
and a deletion of 
one copy of 
320kb 
encompassing 
the 2/3rd of the 
3’ region of 
DOCK8 gene 
and the 5’ part  
of the KANK1 
gene 
male 13 >1,100 - No known allergies 
- Severe eczema 
(lichenification) 
- Eosinophilia 
(>700/mm3) 
Chronic otitis, clavicle 
osteomyelitis, bronchitis, 
pneumonia, 
bronchiectasis, 
Morganella spp., P. 
aeruginosa, Proteus 
mirabillis, H. influenza, 
Giardia intestinalis. 
Sclerosing cholangitis,  
 IgA,  IgM, 
lymphopenia.  
Died of post-HSCT 
complications. 
#12 splice site 
mutation (exon 
11) > frame 
shift, 
homozygous  
male 17 17,045 - Food allergies (pork, 
peanut, chocolate, dairy, 
egg)  
- Severe eczema 
Chronic cutaneous and 
ocular HSV, M. 
contagiosum, warts, S. 
aureus skin infections,  
cutaneous dermatophyte 
infection. 
Chronic liver disease with 
vanishing bile ducts on 
biopsy of unclear etiology. 
Calficied dilated aorta. 
#13 Exon 41: 
c5182C>T 
homozygous 
p.R1728X. 
male 3 24,893 - Food allergies (milk, 
egg, tree nuts, peanut) 
- Severe eczema 
- Asthma 
S. aureus skin infections, 
Herpetic keratitis, warts, 
onchycomycosis, 
bacterial, viral and 
Pneumocystis 
pneumonia. 
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#14 Large deletion + 
stop codon 
(exon 11) 
male 16 51,010 - Eczema 
- Asthma 
Sinopulmonary 
infections, Neisseria 
meningitides arthritis, M. 
contagiosum and warts. 
 
#15 Unknown (lack 
DOCK8 protein; 
see 
Supplementary 
Fig 1) 
male 5 17,300 - Food allergies (milk, 
egg, cashew, pistachio, 
almond, beef, lamb) 
- Eczema 
- Asthma 
- Bronchiectasis 
HSV, S. pyrogenes, H. 
influenzae, C. albicans, 
Adenovirus, Norovirus, 
HHV6, EBV, CMV, 
VZV, Aspergillus Niger, 
Cladosporium. 
 
#16 Unknown (lack 
DOCK8 protein; 
see 
Supplementary 
Fig 1) 
female 4 8,100 - Food allergies (egg, 
milk, macadamia) 
- Environmental allergies 
(house dust mites) 
- Eczema 
- Asthma 
- Allergic rhinitis 
Ocular herpes, recurrent 
lower respiratory tract 
infection, chronic ear 
infections. 
Bell’s Palsy. 
#17 Homozygous 
deletion 
spanning exon 
15-48  
 
female 4 2,294 - Food allergies (peanut 
cashew, pistachio, 
sesame) 
- Sensitization to walnut 
and egg 
- Drug allergy (Propofol) 
- Mild Eczema 
Cryptosporidial 
cholangitis, chronic 
adenoviral carriage, mild 
M. contagiosum, 
Giardia, non-typhi 
Salmonella, low level 
CMV viraemia, otitis 
externa. 
 
#18 c.12114A>G: p. 
K405R 
female 18,  >10,00
0 
- Food allergies (beans, 
beef, chicken, cow's 
milk, egg, fish, peanut, 
pork, tree nuts, tomato) 
- Environmental allergies 
(dust, dog, grasses, mold) 
- Drug allergies 
(Cefipime, Lactinex, 
Propofol)  
- Eczema (herpeticum) 
S. aureus, H. influenzae,  
Cryptococcal meningitis, 
Acinetobacter baumannii 
sepsis, HSV keratitis, 
herpes zoster virus. 
Delayed puberty. 
Deceased. 
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#19 Homozygous  
for a deletion of 
Exons 28-35 
female 17 8,031 - Food allergies (lentils) 
-  Severe eczema 
Chronic oral HSV, 
sinopulmonary 
infections, 
onychomycosis and 
thrush, S. aureus skin 
infections. 
 
#20 Homozygous 
nonsense 
mutations 
Exon19: 
c.2044G>T, 
p.E682X 
female 11 6,690 - Food allergies eggs, 
milk, nuts, soy, wheat) 
- Severe eczema 
S. aureus skin infections, 
HSV keratitis. 
 
#21 Large deletion 
(exon 21 to end 
of gene) + small 
indel with 
frameshift 
mutation (exon 
12)  
male 25 1,162 - Food allergies (nuts) 
- Eczema 
HSV keratitis, 
sinopulmonary 
infections, extensive 
warts. 
Squamous cell carcinoma 
pre-HSCT. 
#22 Large deletion 
(exon 21 to end 
of gene) + small 
indel with 
frameshift 
mutation (exon 
12) 
female 22 39 - No known allergies Extensive warts, 
sinopulmonary 
infections. 
Severe bronchiectasis. 
#23 Nonsense 
mutation (exon 
17) + small 
indel with 
frameshift 
mutation (exon 
36) 
female 16 180 - Mild eczema M. contagiosum , warts, 
sinopulmonary 
infections. 
EBV-B cell lymphoma. 
#24 Large deletion 
(exons 13 to 26) 
male 12 1,563 - Food allergies (tree 
nuts) 
Extensive warts, 
sinopulmonary 
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The following patients were used in these experiments:  
• phenotyping (#1-18);  
• ex vivo cytokine and in vitro differentiation (#1, #2, #6, #7, #9, #10, #15, #17, #18);  
• plasma IgE (#6, #12, #14, #15, #17, #19-28) 
 
+ splicing 
mutation (intron 
5) 
- Mild eczema infections, S. aureus 
osteomyelitis. 
#25 Large deletion 
(promoter to 
exon 17) + 
nonsense 
mutation (exon 
8) 
female 19 5,604 - Food allergies (milk, 
egg, wheat, nuts) 
- Asthma 
- Moderate eczema 
Sinopulmonary 
infections, warts and M. 
contagiosum, 
Pneumocystis 
pneumonia, S. aureus 
skin infections, mucosal 
candidiasis. 
Burkitt’s lymphoma (EBV 
negative), vasculopathy of 
mid-aorta with bilateral 
renal artery stenosis, heart 
failure, improved post 
HSCT. 
#26 Homozygous 
deletion of at 
least exons 4-13 
female 9 2 - Asthma,  
- Mild eczema 
Sinopulmonary 
infections, warts. 
 
#27 Homozygous 
deletion of exon 
36 
female 20 >6,000 - Food allergies (milk, 
kiwi) 
- Asthma 
- Moderate eczema 
Sinopulmonary 
infections, warts, chronic 
cutaneous HSV. 
Cerebral vasculopathy 
with stroke and aortic 
vasculopathy. 
#28 large 
homozygous 
deletion of more 
than 174 kb 
affecting most 
of DOCK8 
(260876_43519
0) from intron 1 
to exon 39 
female 12 1,855-
8,460 
- Food allergies (egg and 
lentils) 
- Eczema 
- Eosinophilia 
(1,532/mm3) 
Diarrhea, upper 
respiratory infections, 
recurrent 
meningoencephalitis, 
chronic otitis media, 
esophageal candidiasis, 
lower urinary tract 
infection, pyelonephritis 
(twice), Pseudomonas sp 
(ear), E. coli. 
Failure to thrive (short 
stature), mild scoliosis, 
seronegative hepatitis, 
liver steatosis, mild 
hepatosplenomegaly, 
extensive abdominal 
vasculitis, elevated liver 
enzymes, IgA  IgG, 
IgM, CD3+ lymphopenia 
(600/ml). 
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